What is the recommended protocol for continuous intravenous insulin infusion in the treatment of hyperkalemia?

Continuous Insulin Infusion for Hyperkalemia

For acute hyperkalemia treatment, administer 10 units of regular insulin IV with 25 grams of dextrose (50 mL of D50) over 15-30 minutes as the standard approach, rather than continuous infusion. 1

Standard Acute Management Protocol

The 2010 American Heart Association guidelines establish the definitive acute treatment regimen 1:

• Insulin dosing: Mix 25 g glucose (50 mL of D50) with 10 units regular insulin and give IV over 15-30 minutes
• This shifts potassium into cells within 30-60 minutes
• Effect is temporary and may need to be repeated

Pediatric Dosing

For children, the protocol differs 2:

• 0.1 unit/kg IV with 400 mg/kg glucose
• Ratio maintained at 1 unit of insulin for every 4 grams of glucose
• Monitor glucose and potassium hourly

When Continuous Infusion May Be Considered

Continuous insulin infusion is NOT the standard first-line approach but may be used in specific refractory situations 3, 4:

• Severe hyperkalemia (K+ >12 mmol/L) unresponsive to bolus therapy
• When dialysis is unavailable or delayed
• Cases requiring prolonged potassium control (8-12 hours)

Continuous Infusion Protocol (Non-Standard)

Based on limited case series evidence 3, 4, 5:

• Start with standard bolus first
• If inadequate response, consider continuous infusion
• Monitor glucose hourly and potassium every 2 hours
• Duration typically 8-12 hours until dialysis available

Critical Safety Considerations

Hypoglycemia is the major complication, occurring in approximately 20% of patients 6:

High-Risk Patients for Hypoglycemia 7, 8:

• Non-diabetic patients
• Female gender
• Renal impairment (90% of hypoglycemia cases had renal dysfunction) 8
• Lower body weight
• Low baseline glucose

Preventing Hypoglycemia 7, 9:

• Use 5 units insulin instead of 10 units in patients with CrCl <30 mL/min 9
• Administer 50 grams dextrose (not 25 grams) with 10 units insulin 7
• Consider dextrose infusion rather than bolus to sustain effect 7
• Monitor glucose hourly for at least 4-6 hours after insulin administration 7
• Omit dextrose if baseline glucose >250 mg/dL 9

Monitoring Requirements

For IV insulin administration 10:

• Blood glucose monitoring every 1-2 hours minimum 11
• Potassium levels every 2-4 hours 12
• Continuous cardiac monitoring if K+ >6.5 mmol/L or ECG changes present 13
• Watch for hypokalemia as insulin shifts potassium intracellularly 10

Complete Acute Hyperkalemia Algorithm

Priority order of interventions 1, 13:

1. Stabilize cardiac membrane (if K+ ≥6.5 mmol/L or ECG changes):

   • Calcium chloride 10%: 5-10 mL IV over 2-5 minutes OR
   • Calcium gluconate 10%: 15-30 mL IV over 2-5 minutes

2. Shift potassium intracellularly:

   • Insulin/glucose as above (primary therapy)
   • Nebulized albuterol 10-20 mg over 15 minutes (synergistic effect) 1, 13
   • Sodium bicarbonate 50 mEq IV only if metabolic acidosis present 1

3. Promote potassium excretion:

   • Furosemide 40-80 mg IV if volume overloaded 1
   • Consider newer potassium binders (patiromer, sodium zirconium cyclosilicate) 14, 13
   • Dialysis for refractory cases or ESRD 13

Key Pitfalls to Avoid

• Do NOT use continuous insulin infusion as first-line therapy - bolus dosing is standard 1
• Do NOT give insulin without adequate glucose unless baseline glucose >250 mg/dL 9
• Do NOT stop glucose monitoring after 2 hours - insulin effects persist 4-6 hours 7
• Do NOT use sodium polystyrene sulfonate (Kayexalate) - questionable efficacy and GI risks 15
• Avoid rapid administration of concentrated dextrose - associated with cardiac arrest and paradoxical hyperkalemia 11

The evidence strongly supports bolus insulin-dextrose therapy over continuous infusion for acute hyperkalemia management, with continuous infusion reserved only for exceptional refractory cases where dialysis is unavailable.